Abbott Laboratories Statistics

Total Valuation

Abbott Laboratories has a market cap or net worth of GBP 157.59 billion. The enterprise value is 163.55 billion.

Market Cap	157.59B
Enterprise Value	163.55B

Important Dates

The next estimated earnings date is Wednesday, January 22, 2025.

Earnings Date	Jan 22, 2025
Ex-Dividend Date	Jan 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.72B

Valuation Ratios

The trailing PE ratio is 36.77.

PE Ratio	36.77
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	24.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.39, with an EV/FCF ratio of 33.80.

EV / Earnings	38.16
EV / Sales	4.99
EV / EBITDA	18.39
EV / EBIT	27.05
EV / FCF	33.80

Financial Position

The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.38.

Current Ratio	1.60
Quick Ratio	1.00
Debt / Equity	0.38
Debt / EBITDA	1.35
Debt / FCF	2.32
Interest Coverage	13.06

Financial Efficiency

Return on equity (ROE) is 14.84% and return on invested capital (ROIC) is 8.76%.

Return on Equity (ROE)	14.84%
Return on Assets (ROA)	6.49%
Return on Capital (ROIC)	8.76%
Revenue Per Employee	269,754
Profits Per Employee	37,593
Employee Count	114,000
Asset Turnover	0.56
Inventory Turnover	2.70

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.02%
50-Day Moving Average	116.12
200-Day Moving Average	110.70
Relative Strength Index (RSI)	46.57
Average Volume (20 Days)	29,326

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.64

Income Statement

In the last 12 months, Abbott Laboratories had revenue of GBP 30.75 billion and earned 4.29 billion in profits. Earnings per share was 2.45.

Revenue	30.75B
Gross Profit	17.19B
Operating Income	5.67B
Pretax Income	5.06B
Net Income	4.29B
EBITDA	8.08B
EBIT	5.67B
Earnings Per Share (EPS)	2.45

Full Income Statement

Balance Sheet

The company has 5.81 billion in cash and 11.23 billion in debt, giving a net cash position of -5.42 billion.

Cash & Cash Equivalents	5.81B
Total Debt	11.23B
Net Cash	-5.42B
Net Cash Per Share	n/a
Equity (Book Value)	29.86B
Book Value Per Share	17.12
Working Capital	6.64B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.51 billion and capital expenditures -1.67 billion, giving a free cash flow of 4.84 billion.

Operating Cash Flow	6.51B
Capital Expenditures	-1.67B
Free Cash Flow	4.84B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 55.91%, with operating and profit margins of 18.44% and 13.99%.

Gross Margin	55.91%
Operating Margin	18.44%
Pretax Margin	16.44%
Profit Margin	13.99%
EBITDA Margin	26.26%
EBIT Margin	18.44%
FCF Margin	15.74%

Dividends & Yields

This stock pays an annual dividend of 1.72, which amounts to a dividend yield of 1.52%.

Dividend Per Share	1.72
Dividend Yield	1.52%
Dividend Growth (YoY)	5.21%
Years of Dividend Growth	5
Payout Ratio	65.30%
Buyback Yield	0.12%
Shareholder Yield	1.64%
Earnings Yield	2.70%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 1, 1998. It was a forward split with a ratio of 2.

Last Split Date	Jun 1, 1998
Split Type	Forward
Split Ratio	2

Scores

Abbott Laboratories has an Altman Z-Score of 5.04.

Altman Z-Score	5.04
Piotroski F-Score	n/a